{"name":"Jin Hyoung Kang","slug":"jin-hyoung-kang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBhR3JUbmpvczZ3elh5MUlWOWlCNlJtcnUzY29CZ3BhZDAtU2VmVEVUQ0xKaDZTSVNaTkp3bVl6eXlrZ3F5OE1KZXZjcVpkeEZFTU1kX0hCMWNaQzUxNGRiUzNzQ2diV3lBNnJhbXR3?oc=5","date":"2026-03-16","type":"pipeline","source":"팜이데일리","summary":"Oscotec mends rift with shareholders…tailwinds for Onconic and AbClon [K-Bio Pulse] - 팜이데일리","headline":"Oscotec mends rift with shareholders…tailwinds for Onconic and AbClon [K-Bio Pulse] - 팜이데일리","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE01MnNNeVlDN01qWnVXNnhoZnV2cGoxZVRPaWhlOHNNSEpyMmJiMGNZdjE2QmlkbkQzUjZ6Qi00czlkcFNGSlkxYUgzU1lWMWFzM0ZkdThNdXNmaE85VXNfOTBFeGxOalJ0am9CWXln0gFyQVVfeXFMT0hueVFhaVF3Z1FRRk03anktRDJYRGNTQmFzX3VveHRMMFdjTk10T0pnWnVQUldrRDhFWWhyWDFva0lDVURkLXJ1UmdIUHM0QmllVXdrclZuRjV5OUxhc0hXODlxbEpLZTR2elhWN0g1QUV3?oc=5","date":"2025-02-24","type":"pipeline","source":"koreabiomed.com","summary":"K-aesthetics industry booms amid leadership shake-ups and expansion schemes - koreabiomed.com","headline":"K-aesthetics industry booms amid leadership shake-ups and expansion schemes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5PN3VQckQxdTAyMFI2QVY2dlluTWRxMDF3UG4tYUxOb2R5Qi1MYXJiUTZaODRhTlFCN2hOLUE4M2EzYXM4enMzMzA2ZXZwbmNJVVlicnJHdEZ0LWdhSFlEbDZEcHNZSUR4cHc?oc=5","date":"2023-08-28","type":"trial","source":"Wiley Online Library","summary":"First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial ","headline":"First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Upd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE1ZYjh6VGM2dkVDUUF6NjFqWHNyVmxFcG40M1RqaWtxd0ZfcVQwbG5OVFpUYmh1MEdEczBIQm1KYkpMbjJ4N1J5YUhiUkxXQlhhWVBrU3FiUmE0V2tXT2RLU3RBQ2w?oc=5","date":"2020-03-04","type":"pipeline","source":"아시아경제","summary":"[Photo] Government Reviews Plan for Mask Sales at Pharmacies - 아시아경제","headline":"[Photo] Government Reviews Plan for Mask Sales at Pharmacies - 아시아경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBTZDZPQWU1enA0WVIxNWtKR1VYU1lhaDl6dDdaTGhOc2FOT0s3V3FDV3JwcTJpQ2ZQbTlHd0lkTmRIUzB2MFFfNFJ5UWVvdHBWeVF2d3ZrcVpTM0Y0Q1htOUlaTUs?oc=5","date":"2020-02-27","type":"pipeline","source":"아시아경제","summary":"[Click eStock] \"Pharmaceutical Stocks Must Increase Western Market and B2B Share to Withstand COVID-19 Fear\" - 아시아경제","headline":"[Click eStock] \"Pharmaceutical Stocks Must Increase Western Market and B2B Share to Withstand COVID-19 Fear\" - 아시아경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9FUnFVcDdWd2swMGs5eEdsY3JCdG5mOTMzcXYtOTNySWVCMWxJcFZ5aFBTa2c3RXgxYWcwQ2Vra05wdnRGbG1SZTFjeXplbVgzUHFHLVRLTzFVQzNIUHZqNjdNUThfTE5lN3lFbdIBcEFVX3lxTFBTSHdYUHlGUGF5b1EwaDFmQmJlTkk0NWV4ZDhnMEI4a3NoQ011aE9XeVFHd2NZd3AtUlRqaFBsX3RzbVN6QkJoTVJTVllGSXk1bkEwV0NFWGt2NU82ZS0yN2syOVR3NVkzeVpXelhJa0M?oc=5","date":"2017-09-14","type":"pipeline","source":"koreabiomed.com","summary":"Opdivo vs. Keytruda - which will doctors choose? - koreabiomed.com","headline":"Opdivo vs. Keytruda - which will doctors choose?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}